Fatma Şen

1.4k total citations
73 papers, 1.0k citations indexed

About

Fatma Şen is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Fatma Şen has authored 73 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Pulmonary and Respiratory Medicine, 28 papers in Oncology and 10 papers in Molecular Biology. Recurrent topics in Fatma Şen's work include Lung Cancer Treatments and Mutations (10 papers), Lung Cancer Research Studies (8 papers) and Medical Imaging Techniques and Applications (7 papers). Fatma Şen is often cited by papers focused on Lung Cancer Treatments and Mutations (10 papers), Lung Cancer Research Studies (8 papers) and Medical Imaging Techniques and Applications (7 papers). Fatma Şen collaborates with scholars based in Türkiye, United States and Egypt. Fatma Şen's co-authors include Leyla Kılıç, Serkan Keskın, Faruk Taş, Rümeysa Çiftçi, İbrahim Yıldız, Derya Duranyıldız, Adnan Aydıner, Hüseyin Oflaz, Rian Dişçi and Murat Serilmez and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Science Advances.

In The Last Decade

Fatma Şen

66 papers receiving 991 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fatma Şen Türkiye 18 488 318 178 162 141 73 1.0k
Mustafa Erman Türkiye 18 401 0.8× 271 0.9× 75 0.4× 84 0.5× 94 0.7× 117 1.0k
İbrahim Güllü Türkiye 19 453 0.9× 423 1.3× 61 0.3× 144 0.9× 261 1.9× 92 1.2k
Kosuke Kashiwabara Japan 18 463 0.9× 457 1.4× 88 0.5× 137 0.8× 258 1.8× 95 1.4k
Atul Batra India 16 309 0.6× 192 0.6× 162 0.9× 125 0.8× 150 1.1× 122 881
Seong Yoon Yi South Korea 22 487 1.0× 466 1.5× 80 0.4× 128 0.8× 301 2.1× 70 1.2k
Wolfgang Lamm Austria 20 494 1.0× 333 1.0× 67 0.4× 105 0.6× 79 0.6× 76 1.0k
Karynsa Cetin United States 13 487 1.0× 367 1.2× 160 0.9× 58 0.4× 294 2.1× 39 1.1k
Elizabeth Healey United States 10 285 0.6× 419 1.3× 158 0.9× 174 1.1× 153 1.1× 17 1.0k
Takanori Ayabe Japan 17 754 1.5× 461 1.4× 67 0.4× 192 1.2× 156 1.1× 103 1.2k
Kristen M. Sanfilippo United States 19 311 0.6× 158 0.5× 288 1.6× 102 0.6× 188 1.3× 101 1.2k

Countries citing papers authored by Fatma Şen

Since Specialization
Citations

This map shows the geographic impact of Fatma Şen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fatma Şen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fatma Şen more than expected).

Fields of papers citing papers by Fatma Şen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fatma Şen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fatma Şen. The network helps show where Fatma Şen may publish in the future.

Co-authorship network of co-authors of Fatma Şen

This figure shows the co-authorship network connecting the top 25 collaborators of Fatma Şen. A scholar is included among the top collaborators of Fatma Şen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fatma Şen. Fatma Şen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Abdelhafez, Yasser G., Cyrus Bateni, Sonia Lee, et al.. (2025). MRI of atypical lipomatous tumor: does contrast help? A multicenter study. PubMed. 54(12). 2681–2693.
3.
Mingels, Clemens, Benjamin A. Spencer, Negar Omidvari, et al.. (2024). Dose Reduction in Pediatric Oncology Patients with Delayed Total-Body [18F]FDG PET/CT. Journal of Nuclear Medicine. 65(7). 1101–1106. 15 indexed citations
4.
Çelik, Betül, et al.. (2024). Germline mutational variants of Turkish ovarian cancer patients suspected of Hereditary Breast and Ovarian Cancer (HBOC) by next-generation sequencing. Pathology - Research and Practice. 254. 155075–155075. 1 indexed citations
5.
Omidvari, Negar, Terry Jones, Pat Price, et al.. (2023). First-in-human immunoPET imaging of COVID-19 convalescent patients using dynamic total-body PET and a CD8-targeted minibody. Science Advances. 9(41). eadh7968–eadh7968. 25 indexed citations
6.
Abdelhafez, Yasser G., Edwin K. Leung, Benjamin A. Spencer, et al.. (2022). Blanching Defects at Pressure Points: Observations from Dynamic Total-Body PET/CT Studies. Journal of Nuclear Medicine Technology. 50(4). 327–334. 1 indexed citations
7.
Şendur, Mehmet Alı Nahıt, Burcu Çakar, Sercan Aksoy, et al.. (2021). 124P Talazoparib in locally advanced or metastatic breast cancer patients: Experience from an early access program in Turkey. Annals of Oncology. 32. S74–S74. 1 indexed citations
8.
Şen, Fatma, Serap Oflaz, Makbule Tambaş, et al.. (2016). Effect of the childhood trauma on the adjustment to cancer in the patients with breast cancer. Breast Cancer. 24(4). 544–551. 5 indexed citations
9.
Karanlık, Hasan, İlker Özgür, Hilal Oğuz, et al.. (2016). Effect of intraperitoneal cetuximab administration on colonic anastomosis and early postoperative adhesion formation in a rat model. Turkish Journal of Surgery. 32(3). 157–161. 3 indexed citations
10.
11.
Yıldız, İbrahim, Fatma Şen, Meltem Ekenel, et al.. (2013). Prognostic Factors Associated with the Response to Sunitinib in Patients with Metastatic Renal Cell Carcinoma. Current Oncology. 20(6). 546–553. 12 indexed citations
12.
Elitok, Ali, Fahrettin Öz, Ahmet Yaşar Çizgici, et al.. (2013). Effect of carvedilol on silent anthracycline-induced cardiotoxicity assessed by strain imaging: A prospective randomized controlled study with six-month follow-up. Cardiology Journal. 21(5). 509–515. 97 indexed citations
13.
Taş, Faruk, İbrahim Yıldız, Leyla Kılıç, et al.. (2013). Same Chemotherapy Regimen Leads to Different Myelotoxicity in Different Malignancies. American Journal of Therapeutics. 23(3). e670–e679. 7 indexed citations
14.
Taş, Faruk, Rümeysa Çiftçi, Leyla Kılıç, et al.. (2012). Clinical and prognostic significance of coagulation assays in melanoma. Melanoma Research. 22(5). 368–375. 15 indexed citations
15.
Taş, Faruk, Leyla Kılıç, Elif Bilgin, et al.. (2012). Clinical and Prognostic Significance of Coagulation Assays in Advanced Epithelial Ovarian Cancer. International Journal of Gynecological Cancer. 23(2). 276–281. 25 indexed citations
16.
Taş, Faruk, Fatma Şen, Hatice Odabaş, et al.. (2012). Performance status of patients is the major prognostic factor at all stages of pancreatic cancer. International Journal of Clinical Oncology. 18(5). 839–846. 91 indexed citations
17.
Şen, Fatma, et al.. (2011). Postprandial platelet-poor plasma 5-hydroxytryptamine concentrations during diarrhea and constipation periods of alternatingtype irritable bowel syndrome patients. The Turkish Journal of Gastroenterology. 22(3). 270–278. 3 indexed citations
18.
Şen, Fatma, Esra Sağlam, Alper Toker, et al.. (2011). Weekly docetaxel and cisplatin with concomitant radiotherapy in addition to surgery and/or consolidation chemotherapy in stage III non-small cell lung cancer. Cancer Chemotherapy and Pharmacology. 68(6). 1497–1505. 3 indexed citations
19.
Karanlık, Hasan, Sıdıka Kurul, Pınar Saip, et al.. (2011). The role of antibiotic prophylaxis in totally implantable venous access device placement: results of a single-center prospective randomized trial. The American Journal of Surgery. 202(1). 10–15. 44 indexed citations
20.
Şen, Fatma, Atahan Çağatay, Halit Özsüt, et al.. (2008). An unusual association of cutis verticis gyrata with empty sella. European Journal of Internal Medicine. 19(6). e23–e25. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mustafa Erman Breakdown of academic impact, for papers by İbrahim Güllü Breakdown of academic impact, for papers by Kosuke Kashiwabara Breakdown of academic impact, for papers by Atul Batra Breakdown of academic impact, for papers by Seong Yoon Yi Breakdown of academic impact, for papers by Wolfgang Lamm Breakdown of academic impact, for papers by Karynsa Cetin Breakdown of academic impact, for papers by Elizabeth Healey Breakdown of academic impact, for papers by Takanori Ayabe Breakdown of academic impact, for papers by Kristen M. Sanfilippo
Rankless by CCL
2026